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Abstract
Background Ethyl glucuronide (EtG) in hair has emerged
as a useful biomarker for detecting alcohol abuse and
monitoring abstinence. However, there is a need to establish
a reliable cutoff value for the detection of chronic and
excessive alcohol consumption.
Methods One hundred and twenty-five subjects were classi-
fied as teetotalers, low-risk drinkers, at-risk drinkers, or heavy
drinkers. The gold standard for subjects' classifications was
based on a prospective daily alcohol self-monitoring log.
Subjects were followed for a 3-month period. The EtG
diagnostic performance was evaluated and compared with
carbohydrate-deficient transferring (CDT) and the activities
of aspartate aminotransferase, alanine aminotransferase, and
γ-glutamyl-transferase (γGT).
Results A cutoff of >9 pg/mg EtG in hair, suggesting an
alcohol consumption of >20/30 g (at-risk drinkers), and a
cutoff of >25 pg/mg, suggesting a consumption of >60 g
(heavy drinkers), were determined by receiver operating
characteristic analysis. The EtG diagnostic performance was
significantly better (P<0.05) than any of the traditional
biomarkers alone. EtG, as a single biomarker, yielded a
stronger or similar diagnostic performance in detecting at-risk
or heavy drinkers, respectively, than the best combination of
traditional biomarkers (CDT and γGT). The combination of
EtG with traditional biomarkers did not improve the diagnos-
tic performance of EtG alone. EtG demonstrated a strong
potential to identify heavy alcohol consumption, whereas the
traditional biomarkers failed to do so. EtG was not signifi-
cantly influenced by gender, body mass index, or age.
Conclusion Hair EtG definitively provides an accurate and
reliable diagnostic test for detecting chronic and excessive
alcohol consumption. The proposed cutoff values can serve
as reference for future cutoff recommendations for clinical
and forensic use.
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Chronic and excessive alcohol consumption is recognized
as a major public health concern. In Western Europe, it is
estimated that 20% of the population have chronic and
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excessive alcohol consumption, including drinkers catego-
rized as at-risk and heavy drinkers. At-risk alcohol
consumption (>20/30 g/day) is associated with a significant
increased risk of disease and premature mortality, and it
imposes a considerable social and economic burden [1, 2].
The early detection of at-risk alcohol consumption is of
particular importance to help reduce alcohol-related injury.
The diagnostic value of the traditional and indirect
biomarkers aspartate aminotransferase (ASAT), alanine
aminotransferase (ALAT), γ-glutamyl-transferase (γGT),
and carbohydrate-deficient transferring (CDT) is often
limited by their lack of sensitivity and/or specificity, as
increased values can be due to numerous other non-
alcoholic disorders [3–5]. A combination of traditional
biomarkers is thus recommended to improve the diagnosis
[3, 6–10].
Ethyl glucuronide (EtG) is a promising biomarker of
alcohol consumption. In contrast to traditional biomarkers,
EtG is a direct metabolite of ethanol that is exclusively
produced in vivo following alcohol consumption. EtG is
incorporated into hair, which makes its analysis an effective
and non-invasive method to monitor retrospective alcohol
consumption over a long period of time (weeks/months).
Several studies have investigated the potential of hair EtG
as a marker of alcohol consumption [11–16]. Overall, EtG
was not detected in the hair of teetotalers. Heavy drinkers
(>60 g/day) displayed considerably higher hair EtG
concentrations than the so-called social drinkers (≤60 g/day).
In addition, the levels of hair EtG seemed to reflect the
average daily amount of alcohol ingested [17, 18].
Various cutoff values (4, 23, 25, 30, and 50 pg/mg) have
been proposed to detect chronic and excessive alcohol
drinkers [14, 17, 19–21]. Despite the >30-pg/mg cutoff
consensus of the Society of Hair Testing (SoHT) from 2009
for heavy drinkers [22], there is no general agreement
regarding the cutoff values that should be used.
A study conducted with 154 persons in a driving ability
assessment used cutoff values of >7 pg/mg for social drinking
between 20 and 40 gethanol/day and >30 pg/mg for heavy
drinking (>60 g/day) [23]. Hair EtG concentrations were
compared with the plasma %CDT. In contrast to 53 persons
tested with hair EtG >30 pg/mg, CDT was detected above
the routinely used upper limit in 15 cases only.
Only one retrospective study based on self-reports integrated
statistical components in order to validate the performance of
EtG in hair [24]. Twenty-seven picograms per milligram has
been proposed as cutoff value to identify heavy drinkers with
a sensitivity of 0.92 and a specificity of 0.96.
A recently published Swedish study measured EtG in
hair after the controlled daily ethanol consumption of 16 g
(14 female volunteers) or 32 g (7 male volunteers) of over a
3-month period [25]. EtG could be detected in the hair of
six from seven volunteers with a consumption of 32 g/day
and in lower concentrations in 6 of 14 cases with a
consumption of 16 g/day. They concluded that EtG
determination in hair can not totally exclude minor daily
alcohol consumption and lacks sensitivity for the purpose
of monitoring total abstinence.
An inaccurate estimation of alcohol consumption may
lead to a misclassification of a subject and to unreliable
cutoff values. The choice of a gold standard is thus a key
element to ensure the validity of results. The assessment of
alcohol consumption relies on either retrospective or
prospective methods. Retrospective methods have been
associated with a lack of compliance and missing data due
to the need for subjects to recall alcohol consumption over
extended periods [26]. Prospective alcohol self-monitoring
logs represent a superior alternative to retrospective, self-
reported methods. They allow the subject to collect more
accurate alcohol consumption data on a daily or a drink-by-
drink basis and do not require that subjects recall their
alcohol consumption [27, 28]. To our knowledge, there
have been no studies evaluating the diagnostic performance
of hair EtG using a prospective, self-monitoring method as
a gold standard.
The main objective of this prospective study was to
assess the relevance of hair EtG as a marker of alcohol
consumption in a well-characterized population. For this
purpose, reliable cutoff values to identify chronic and
excessive alcohol consumption were determined using
statistical analyses. The diagnostic performance of hair
EtG was evaluated and compared with traditional bio-
markers alone, or in combination. Finally, the influence of




This prospective study was conducted between March 2009
and June 2010 over a 3-month test period at the University
Center of Legal Medicine, Lausanne. One hundred and
forty subjects were recruited by advertisement in the local
newspapers and by posters displayed in public places.
Eligible subjects were above 18 years old, not pregnant,
and with no cognitive impairment. Subjects with intrave-
nous drug abuse were not authorized to participate in this
study. Of the 140 subjects, ten did not meet the eligibility
criteria, and five withdrew from the study. Full data were
obtained from 125 subjects (69 women, 56 men) who
completed the study. All participants provided written
informed consent before enrollment. The study protocol
was approved by the Clinical Research Ethics Committee
of the University of Lausanne.
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Daily alcohol self-monitoring log
The subjects' daily alcohol consumption was estimated
using a Daily Alcohol Self-Monitoring log (DASM log)
recorded over the 3-month study period. They were
requested to report their alcohol consumption on a day-
by-day basis using weekly calendars. The DASM log
allowed to collect prospectively detailed quantitative and
qualitative information about number, volume, frequency,
and type of drinks (categorized as beer, wine, fortified
wine, and spirit) consumed each day. The mean daily
alcohol consumption (grams per day) was calculated based
on alcohol content, reported volume, and frequency of
drinking. Beer, wine, fortified wine, and spirit alcohol
contents were defined as 5%, 12%, 20%, and 40% (v/v),
respectively.
Identification of subjects' alcohol consumption profile
Subjects were classified into three categories (teetotaler, low-
risk, and at-risk drinkers) based on the results from the DASM
log. Teetotalers were defined as subjects who declared total
abstinence from alcohol consumption (0 g/day) during the last
12 months. Low-risk drinkers were defined as subjects who
consumed ≤20 g/day for women and ≤30 g/day for men. At-risk
drinkers were defined as subjects who consumed >20 g/day for
women and >30 g/day for men. These thresholds are based on
WHO recommendations. To allow a direct comparison of our
findings with results reported in the literature, subjects with an
alcohol consumption of >60 g/day for both men and women
were also classified and were referred to as heavy drinkers.
Study design
Subjects were required to attend three visits: at weeks 0, 6,
and 12. The first interview consisted of introducing the
purpose and design of the study. Information, including
gender, age, body weight, body height, hair natural color,
and hair cosmetic treatment, was collected. The DASM log
was explained and handed out to each subject. Subjects
were asked to complete and return the DASM log every
week over the study period. Blood samples were taken at
all visits, and hair at the first and the last one. The DASM
logs were checked at week 6 and the end of the protocol.
Blood and hair collection
Blood samples were collected in Sarstedt S-Monovette®
Serum Gel tubes, which were immediately centrifuged. Two
milliliters of serum were separated and stored at −20°C until
analysis. Hair samples were collected from the vertex
posterior region, as close as possible to the skin. The 3-cm
proximal hair segment, representing approximately 3 months
of growth [29], was used for EtG analysis. Hair samples were
stored dry and kept away from light at room temperature until
analysis.
Serum and hair analysis
Traditional biomarkers (ASAT, ALAT, γGT, and CDT) were
analyzed in all serum samples. ASAT, ALAT, and γGT were
measured by immunoassay on a Dimension® Xpand® Plus
clinical chemistry system (Siemens). CDT was analyzed by
capillary zone electrophoresis, equipped with a UV detector
set at 210 nm, using a commercial assay kit (CEofix™ CDT,
Analis). CDT was expressed as the percent of asialo- plus
disialo-transferrin isoforms in total transferrin.
Hair EtG was analyzed using a fully validated gas
chromatography-tandem mass spectrometry (GC-MS/MS)
method [30]. The limit of detection and the limit of
quantification (LOQ) were 2 and 4 pg/mg hair, respectively.
Data analysis
Statistical analyses were performed using STATA® version
11 and R version 2.9.2 software. Mean, standard deviation,
median, and interquartile range (25–75%) were used as
descriptive statistics. Continuous variables were compared
using the Kruskal–Wallis test and the Mann–Whitney U test
(one-tailed); categorical variables were compared using the
χ2 test (two-tailed). The diagnostic performance of EtG,
ASAT, ALAT, γGT, and CDT (sensitivity, specificity,
positive predictive value, and negative predictive value)
was calculated for the optimal cutoff values selected from
the receiver operating characteristic (ROC) curves (i.e., the
value on the ROC curve farthest from the diagonal line
[chance] optimizing both sensitivity and specificity). The
diagnostic performance of each test was compared using
the area under the ROC curves (AUROC). An AUROC
closer to 1 indicated a better diagnostic test, while an
AUROC of 0.5 indicated no diagnostic ability. Univariate
logistic regression analysis was performed to evaluate the
independent effects of age, gender, and BMI on the EtG
diagnostic performance, expressed as an odds ratio (OR).
Multivariate logistic regression analysis was performed to
determine the combination among the five biomarkers that
could best predict excessive alcohol consumption. P<0.05
was considered statistically significant.
Results
Descriptive results
One hundred and twenty-five subjects were classified
according to their self-reported alcohol consumption. The
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demographic and reported alcohol intake characteristics and
biomarker levels are presented in Table 1. Forty-three
subjects did not report any alcohol consumption, 44
subjects reported an alcohol consumption ≤20/30 g/day
(women/men), and 38 subjects reported an alcohol con-
sumption >20/30 g/day (women/men). Twenty-one subjects
had an alcohol consumption >60 g/day. There were no
significant differences in age and BMI, whereas significant
differences were noted in gender between the three groups.
Women were less likely than men to report at-risk
consumption.
The median EtG concentration varied among the groups
and was significantly higher in at-risk drinkers than in low-risk
drinkers (Mann–Whitney U test, P<0.001). The median
values of γGT and CDT were also significantly higher in
at-risk drinkers than in low-risk drinkers (Mann–Whitney
U test, P<0.001). This difference, though significant, was
less apparent with the median values of ASAT and ALAT
(Mann–Whitney U test, P<0.05). Heavy drinkers showed
significantly higher EtG, ASAT, ALAT, γGT, and CDT levels
than the subjects who consumed ≤60 g/day (Mann–Whitney
U test, P<0.001). Notably, significantly elevated biomarker
values were observed in heavy drinkers, as compared with
at-risk drinkers (Mann–Whitney U test, P<0.01).
Determination of optimal cutoff values and diagnostic
performance of EtG
Table 2 lists the EtG diagnostic performance for each optimal
cutoff value. ROC analyses were performed to determine the
optimal EtG cutoff value, to allow distinguishing at-risk
drinkers from the others. The optimal cutoff value was set at
Table 1 Demographic and alcohol intake characteristics and biomarker levels (EtG measured in hair; ASAT, ALAT, GGT, and CDT measured in
plasma) for 125 subjects classified according to their self-reported alcohol consumption
Teetotalers (n=43) Low-risk drinkers (n=44) At-risk drinkers (n=38) P -value*
Gender <0.001
Women, n (%) 29 (67) 30 (68) 10 (26)
Men, n (%) 14 (33) 14 (32) 28 (74)
Age, years 0.051
Mean ± SD [(range]) 37.5±16.7 [(19–74]) 35.3±13.1 [(20–67]) 42.3±14.0 [(19–70])
Median (IQR) 32.0 (24.0–52.0) 30.0 (25.0–42.0) 41.5 (31.0–54.0)
BMI (kg/m2) 0.289
Mean ± SD [(range]) 22.8±3.4 [(15–32]) 23.7±3.0 [(18–33]) 23.9±4.2 [(19–40])
Median (IQR) 22.5 (20.0–24.6) 23.8 (21.6–24.8) 22.6 (21.2–25.6)
Daily alcohol consumption (g/day)
Mean ± SD [(range]) 0 8.7±7.2 [(0–30]) 64.4±34.5 [(21–150])
Median (IQR) 0 7.9 (3.1–11.3) 52.5 (36.1–88.0)
Laboratory parameters
EtG (pg/mg) <0.001
Mean ± SD [(range]) 0.6±2.1 [(0–10]) 4.9±6.2 [(0–32]) 88.3±203.9 [(1–1,190])
Median (IQR) 0.0 (0.0–0.0) 3.5 (1.3–6.4) 31.9 (11.9–82.4)
ASAT (U/l) 0.022
Mean ± SD [(range]) 19.7±6.3 [(9–38]) 18.2±6.2 [(5–37]) 27.1±16.3 [(12–82])
Median (IQR) 18.8 (15.7–25.0) 17.7 (13.6–20.8) 19.3 (15.9–34.9)
ALAT (U/l) 0.027
Mean ± SD [(range]) 33.1±8.3 [(19–57]) 31.3±12.6 [(12–89]) 38.1±15.4 [(23–80])
Median (IQR) 31.0 (28.3–38.0) 27.5 (24.7–33.7) 32.2 (26.8–45.5)
γGT (U/l) <0.001
Mean ± SD [(range]) 26.7±10.0 [(9–50]) 33.1±14.1 [(10–81]) 67.6±55.1 [(14–215])
Median (IQR) 26.0 (19.0–33.7) 30.0 (25.2–35.9) 43.4 (30.2–96.7)
CDT(%) (asialo- ± disialo-transferrin) <0.001
Mean ± SD [(range]) 0.7±0.2 [(0.2–1.2]) 0.8±0.2 [(0.5–1.6]) 2.1±2.5 [(0.5–11.8])
Median (IQR) 0.6 (0.5–0.8) 0.8 (0.7–0.9) 1.0 (0.8–1.7)
ASAT aspartate aminotransferase; ALAT alanine aminotransferase; γGT γ-glutamyl transferase; CDT carbohydrate-deficient transferring; IQR
interquartile range
*Kruskal-–Wallis test (used to compare the three groups together) and χ2 test were statistically significant at a P- value <0.05.
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>9 pg/mg. Based on this cutoff, the sensitivity of EtG was
0.82 (31 out of 38 at-risk drinkers were correctly classified),
and the specificity was 0.93 (6 out of 87 subjects were
misdiagnosed as at-risk drinkers). The positive and negative
predictive values were 0.84 and 0.92, respectively, meaning
that the probability for a subject with an EtG concentration of
>9 pg/mg to be an at-risk drinker was 84%, and the probability
for a subject with an EtG concentration of ≤9 pg/mg to be a
low-risk drinker was 92%. This cutoff value is thus proposed
as a good indicator of at-risk drinking. The optimal cutoff
value for detecting heavy drinkers was set at >25 pg/mg
(>60 g/day versus the others). EtG had a better diagnostic
performance in detecting heavy drinkers than at-risk drinkers,
with a false negative rate of 5% and a false positive rate of 3%.
Low-risk drinkers showed in 58% of the cases EtG concen-
trations lower than the LOQ of the applied analytical method
of 4 pg/mg. A reliable differentiation between teetotalers and
low-risk drinkers was therefore not possible. A gain in the
sensitivity of the analytical method may allow a distinction
between these groups.
Comparison of diagnostic performances
The AUROC of each biomarker is represented in Fig. 1.
EtG, ASAT, ALAT, γGT, and CDT had AUROC values
greater than 0.5, where 0.5 indicates an ineffective test. The
EtG diagnostic performance was significantly higher than
the traditional biomarkers (P<0.0001). EtG showed the
largest AUROC (0.95; 95% CI, 0.92–0.99) value, followed
by CDT (0.80; 95% CI, 0.71–0.89), γGT (0.76; 95% CI,
0.66–0.86), ASAT (0.65; 95% CI, 0.54–0.76), and ALAT
(0.60; 95% CI, 0.49–0.71). The diagnostic performance of
each biomarker for the detection of heavy drinkers was also
evaluated. All of the biomarkers were better predictors of
heavy than of at-risk alcohol consumption (EtG, 0.99; 95%
CI, 0.98–1.00; CDT, 0.84; 95% CI, 0.75–0.93; γGT, 0.79;
95% CI, 0.65–0.93; ASAT, 0.79; 95% CI, 0.68–0.90;
ALAT, 0.73; 95% CI, 0.62–0.85). The AUROC value for
EtG was significantly higher than that of the other
traditional biomarkers (P<0.001).
Diagnostic performance of combined biomarkers
EtG, as a single biomarker, yielded a similar diagnostic
discriminatory ability in detecting at-risk drinkers as the
Table 2 The diagnostic perfor-
mance of ethyl glucuronide in
detecting abstinence, at-risk
alcohol consumption, and heavy
alcohol consumption
PPV positive predictive value;
NPV negative predictive value;
CI confidence interval
Daily alcohol consumption (g/day)
0 >20/30 >60
Teetotalers vs. others At-risk drinkers vs. others Heavy drinkers vs. others
AUC (95% CI) 0.95 (0.91–0.99) 0.95 (0.92–0.99) 0.99 (0.98–1.00)
Cutoff (EtG, pg/mg) 0 >9 >25
Sensitivity 0.93 0.82 0.95
Specificity 0.94 0.93 0.97
PPV 0.89 0.84 0.88
NPV 0.96 0.92 0.99
Fig. 1 A comparison of the diagnostic performance of ethyl
glucuronide in detecting (a) at–risk alcohol consumption (>20/30 g/day;
women/men) or (b) heavy alcohol consumption (>60 g/day; women and
men) with traditional biomarkers (CDT, γGT, ASAT, and ALAT) using
ROC curve analysis. AUROC, area under the receiver operating
characteristics curve
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best EtG-included biomarker combination, which used EtG,
ALAT, and γGT. The AUROC value of this combination
was 0.96 (95% CI, 0.93–0.99), whereas the AUROC of EtG
alone was 0.95 (95% CI, 0.91–0.99). As a single biomarker,
EtG yielded a stronger diagnostic performance in detecting
at-risk drinkers than any combination of the multiple
traditional biomarkers. In particular, EtG was better in
detecting at-risk drinkers than the best traditional biomarker
combination, which included CDT and γGT (P<0.05). No
significant differences in detecting heavy drinkers were
observed when comparing EtG with the best traditional
biomarker combination (P=0.06).
Effects of intrinsic factors on EtG
A univariate regression analysis of age, gender, and BMI
revealed that none of these variables affected the diagnostic
performance of EtG in identifying chronic and excessive
alcohol consumption (age [OR, 0.95; 95% CI, 0.89–1.01; P=
0.09], gender [OR, 0.86; 95% CI, 0.21–3.45; P=0.83], or
BMI [OR, 1.04; 95% CI, 0.88–1.23; P=0.62]). Based on
these results, no corrections were deemed necessary.
Discussion
Performance diagnostic and cutoff values
The main finding of this study was that hair EtG is a reliable
indicator of chronic and excessive alcohol consumption,
regardless of the subject's age, gender, or BMI.
Hair EtG demonstrates a high diagnostic performance in
diagnosing chronic and excessive alcohol consumption.
Even the best combination of EtG and traditional bio-
markers does not significantly improve the diagnostic
performance of EtG alone. Although EtG alone performed
better in identifying at-risk drinkers than the best combina-
tion of traditional biomarkers, it showed a similar diagnos-
tic performance in identifying heavy drinkers (as shown for
CDT and γGT by Sillanaukee [7]). As expected, all of the
biomarkers performed better in detecting heavy drinkers
than at-risk drinkers. The highest diagnostic performance of
the traditional biomarkers was obtained for the detection of
heavy drinkers (0.73–0.84), whereas the lowest diagnostic
performance was for the detection of at-risk drinkers (0.60–
0.80), with minimum reported values that were not much
higher than would be expected by chance. These findings
are in agreement with previously reported results [3] and
have been attributed to the known increase in the activity of
traditional biomarkers following an alcohol consumption of
over 60–80 g/day, sustained for a 2-week period [8, 31, 32].
Thus, the high amount of alcohol required to increase
traditional biomarker levels makes the early detection of
alcohol misuse particularly difficult. In contrast, EtG is
present even after low to moderate alcohol consumption,
and it allows the identification of at-risk drinkers with a high
diagnostic performance (0.95), as compared to traditional
biomarkers.
To identify heavy drinkers, a robust cutoff value has
been determined: a cutoff value of 25 pg/mg offered the
best combination of sensitivity (0.95) and specificity (0.97).
These results are in agreement with a previous study, which
suggested a cutoff of 27 pg/mg to identify heavy drinkers;
the sensitivity and specificity were 0.92 and 0.96, respec-
tively [24]. Using the 30-pg/mg cutoff recommended by the
SoHT [22], we would have obtained a similar specificity
(0.97); however, sensitivity would have decreased (0.81). In
clinical and forensic practice, ensuring high specificity is
important to reduce false positive results. In this study, the
best specificity was obtained with a cutoff of 39 pg/mg: no
subjects would have been misclassified as heavy drinkers,
though only 81% would have been correctly identified as
heavy drinkers. Similarly, a robust cutoff value was deter-
mined to detect at-risk drinkers. The optimal cutoff value was
9 pg/mg and yielded a sensitivity of 0.82 and a specificity of
0.93. To our knowledge, this is the first study investigating the
usefulness of EtG in detecting at-risk drinking, which is often
an early sign of chronic and excessive alcohol consumption.
A distinction between low-risk drinking and abstinence
under the given analytical limits is not possible because of the
high percentage of negative results in the group of low-risk
drinkers. This limitation may be partially solved in the near
future by upcoming analytical equipments offering a better
sensitivity. However, when EtG is detected in hair, abstinence
can generally be excluded.
Several studies have reported an effect of gender, age, or
BMI on traditional biomarker levels. Interestingly, in this
study, EtG was not affected by gender, age, or BMI. In
addition, earlier studies demonstrated that EtG was likely not
influenced even by hair color [18, 33]. These data support the
relevance of EtG as a reliable biomarker because it does not
require any gender, age, or BMI adjustments. These findings
confirm the trends previously reported [24].
However, worries about artificial positive EtG results
due to cosmetics or food cannot be neglected. A recent
study carried out by Martins et al. [34] did not show false
positive results after hair treatment with ethanol-containing
hair care products. Nevertheless, a contamination by EtG-
containing products cannot be excluded, even if that is
exceptionally as reported in a case presented by Sporkert et
al. [35]. Therefore, the hair treatment should always be
recorded during the sampling. Positive EtG cases in hair
due to food or none-hair cosmetics like mouthwash or hand
sanitizers have not yet been reported in contrast to positive
EtG urine results [36–41]. That can be explained by the
small amount of ethanol ingested or absorbed leading to
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EtG concentrations in urine insufficiently high to produce a
positive EtG findings in hair.
Interpretation and practical considerations
In clinical and forensic practice, EtG has shown a high
potential in monitoring abstinence, identifying a relapse to
drinking, or in diagnosing chronic and excessive alcohol
consumption. The analysis of hair EtG (0–3 cm, a proximal
segment) should be interpreted according to the following
criteria: (1) a hair EtG concentration of 0 to ≤LOQ suggests an
absence of alcohol consumption (teetotalers), although a low-
risk alcohol consumption cannot be ruled out; (2) a EtG
concentration of>LOQ to ≤9 pg/mg suggests low-risk con-
sumption and can exclude abstinence; (3) a EtG concentration
of >9 to ≤25 pg/mg indicates at-risk consumption; and (4) a
EtG concentration >25 pg/mg indicates heavy consumption.
In addition, care should be taken in the interpretation of
hair EtG results to demonstrate a recent abstinence from
alcohol. Because hair growth is irregular, and approximately
15–20% of the hair follicles remain in an inactive cycle phase,
residual EtG can still be detected (rate, approximately 15–
20%) even after the complete cessation of alcohol consump-
tion [42]. Depending on the previous alcohol consumption
behavior, a waiting period, corresponding to the inactive
phase of hair growth, might be recommended when
monitoring abstinence in order to avoid misinterpretations.
For the abstinence control days or a few weeks after the
cessation of alcohol consumption, the detection of EtG and
ethyl sulfate in urine [43, 44] or phosphatidylethanol in
blood [45–47] are therefore a better choice.
In conclusion, hair EtG demonstrates a strong diag-
nostic performance in detecting both at-risk and heavy
alcohol consumption, and it clearly outperforms the
diagnostic performance of the standard traditional bio-
markers. In contrast with traditional biomarkers, age,
gender, and BMI did not affect the EtG diagnostic
performance. The analysis of hair EtG definitively provides
an efficient clinical diagnostic tool to detect chronic and
excessive alcohol consumption. Reliable cutoff values have
been determined which can serve as reference for future cutoff
recommendations in practice to identify alcohol-drinking
behaviors.
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